ArticleCell division2019

M2I-1 disrupts the in vivo interaction between CDC20 and MAD2 and increases the sensitivities of cancer cell lines to anti-mitotic drugs via MCL-1s.

Jianquan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.